



DRUG UTILISATION EVALUATION OF ANTIHYPERTENSIVES IN GERIATRIC PATIENTS IN A 
TERTIARY CARE HOSPITAL 
Original Article 
 
MOHAMMED ALTAF*1, ANAS RASHEED2, ARSHIA MUJTABA1, SHAIK MOHAMMED1 
1Pharm. D, Department of Pharmacy Practice, Deccan School of Pharmacy, Hyderabad-500001, Telangana, INDIA, 2M. Pharm, Department 
of Pharmaceutical Analysis. 
Email: altaf199201@gmail.com  
Received: 20 Jul 2014 Revised and Accepted: 22 Aug 2014 
ABSTRACT 
Objective: Hypertension is a leading contributor to the global burden of cardiovascular morbidity and mortality. The main objective of the present 
study was to assess the drug utilization patterns of antihypertensives in geriatric patients in a teaching hospital. 
Methods: A Single centre Prospective Observational study was carried out for a period of three months in an out-patient department of Owaisi 
Hospital & Research Centre. Elderly patients who have been diagnosed with hypertension as per JNC-7 guidelines and patients receiving or 
prescribed with antihypertensive drugs were included. 
Results: A total of 100 prescriptions were analyzed during the three month study period. 72% of the patients were in the age group of 65-67 years 
and this was found to be higher in men 68%. During the study period 80% of the patients were Pre-Hypertensive systolic (80-89 mmHg) and 
Diastolic (120-139 mmHg) followed by Stage-I Hypertension and Stage-II Hypertension. The most common drug classes involved in the study was 
Calcium Channel Blockers 37% followed by Angiotensin II receptor antagonists 21% and the most commonly prescribed drugs in the study 
population were Amlodipine 37%, Losartan 11% and Telmisartan 10%. The most common anti-hypertensive fixed dose combination therapy 
involved in the study was Telmisartan + Hydrochlorothiazide 15% and most common two drug combination therapy involved in the study was 
Amlodipine + Atenolol 7% followed by Metoprolol + Amlodipine 1%. 
Conclusion: Our study shows that the most commonly prescribed drug classes involved were Calcium Channel Blockers followed by Angiotensin II 
receptor antagonists and the anti-hypertensive drug combinations among hypertensive patients were considerable and this practice positively 
impacted on the overall blood pressure control. 
Keywords: Anti-hypertensives, Blood pressure, Geriatrics, Hypertension, JNC-7 guidelines. 
 
INTRODUCTION 
Hypertension is a leading contributor to the global burden of 
cardiovascular morbidity and mortality. Prevalence of hypertension 
in India in 2000 was 60.4 million males and 57.8 million females and 
projected to increase to 107.3 million and 106.2 million respectively 
in 2025. Hypertension varies from 4-15% in urban and 2-8% in 
rural population.[1] Apart from unhealthy lifestyles, lack of 
awareness about hypertension, distorted public health systems, 
physicians treating hypertension also lag behind in treating 
hypertension according to standard treatment guidelines. Non 
compliance to antihypertensive therapy is also a reason for 
uncontrolled hypertension.[2] Elderly patients commonly have 
multiple pathologies leading to poly pharmacy, and altered 
pharmacokinetics and pharmacodynamics, are prone to adverse 
drug reactions from inappropriate medication.[3,4] At least high 
normal blood pressure (below 140/90 mmHg) in elderly patients as 
mentioned in the Indian Hypertension Guidelines II.[5] The main 
objective of the present study is to assess the prescribing patterns 
for anti-hypertensives in geriatric patients in a teaching hospital.  
MATERIALS AND METHODS 
A Single centre Prospective observational study was carried out for 
a period of three months (August 2013- October 2013) in an out-
patient department of Owaisi Hospital and Research Centre, a 
Teaching Hospital in South India. It is a 1000-bedded Teaching 
Hospital situated in the heart of city at Hyderabad, Telangana, India. 
Ethical approval was obtained from the institutional and hospital 
committee prior to study initiation. Elderly patients of age >65 years 
who have been diagnosed with hypertension as per JNC-7 guidelines 
and patients receiving or prescribed with antihypertensive drugs 
were included.[6] Details necessary for evaluation regarding chief 
complaints of the patients, previous allergies, co-morbidities, and 
others were collected from the patient's clinical records. Certain 
demographic characteristics were studied and the factors studied 
were: (a) patient characteristics [gender, age (>65 years), and 
comorbidities], (b) drug characteristics [list of antihypertensive and 
number of drugs prescribed] and Blood Pressure. The 
Sociodemographic status such as educational qualification, 
occupation, monthly income, and social habits of the patients were 
collected. All data were collected from data collection form, and to 
review the current prescribing patterns of Anti-hypertensive drugs 
in hypertension patients with co-morbidities and without co-
morbidities, use of Anti-Hypertensive Drug monotherapy and 
combination therapy in patient with hypertension. 
RESULTS 
A total of 100 patients were consulted during the three month study 
period, in an out-patient department of Owaisi Hospital and 
Research Centre. Of these 100 prescriptions, 72% of the patients 
were in the age group of 65-67 years, followed by 26% in 68-70 
years and 2% who were >70 years, and this was found to be higher 
in men 68% than in women 32%.  
 
Fig. 1: Gender distribution of patients in the study population (n=100)
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Table 1: Sociodemographic status of the patients 
Sociodemographics Number and Percentage (%) 
Educational Qualifications  
 Literate 76 (76%) 
 Illiterate 24 (24%) 
Occupation  
 Employed 57 (57%) 
 Unemployed 43 (43%) 
Monthly Income  
 <2000 23 (23%) 
 2000-5000 16 (16%) 
 5000-10000 31 (31%) 
 10000-15000 17 (17%) 
 ˃15000 13 (13%) 
Social Habits  
 Alcoholic 15 (15%) 
 Smoker 20 (20%) 
 Both 8 (8%) 
  
 
Fig. 2: Educational Distribution of Patients 
 
 
Fig. 3: Monthly Income of Patients (n=100) in Rupees 
 
The numbers of drugs prescribed were in the range of 4-6 per 
prescription. The Sociodemographic status such as Educational 
qualification, Occupation, Monthly Income, and Social habits of the 
patients were summarized in Table 1. Hypertensive patients are 
classified on the basis of Joint National Committee (JNC-7) were 
summarized in Table 2. The most common drug classes involved in 
the study were Calcium Channel Blockers 37% followed by 
Angiotensin II receptor antagonists 21%, and other prescribing 
patterns of Anti-Hypertensive Drug Monotherapy were summarized 
in Table 3. The most common anti- hypertensive fixed dose 
combination therapies involved in the study were Telmisartan+ 
Hydrochlorothiazide 15% followed by Olmesartan+ 




Fig. 4: Social History of Patients in the Study Population (n=100) 
 
 
Fig. 5: Prescription pattern of Anti-hypertensive drug 
monotherapy 
 
The most common two drug combination therapies involved in the 
study were Amlodipine+ Atenolol 7% followed by Metoprolol+ 
Amlodipine 1%. 
 
Table 2: Classification of hypertensive patients on the basis of JNC-7 













Stage-I Hypertension (140-159 mmHg) 13 (13%) 
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Table 3: Prescription pattern of Anti-hypertensive drug monotherapy 
Anti-hypertensive monotherapy drugs Number and percentage (%) 
Calcium channel blockers  
 Amlodipine 38 (38%) 
Angiotensin II receptor antagonists  
 Losartan 11 (11%) 
 Telmisartan 10 (10%) 
β-blockers  
 Atenolol 6 (6%) 
 Metoprolol 5 (5%) 
Diuretics  
 Hydrochlorothiazide 1 (1%) 
 Furosemide 1 (1%) 
 
Table 4: Use of anti-hypertensive drugs in hypertension patients with co-morbidities 
Co-morbidities Drugs No. and percentage (%) 
Diabetes Mellitus Losartan 3 (3%) 
Telmisartan 4 (4%) 
Amlodipine 5 (5%) 
Telmisartan+Hydrochlorothiazide 1 (1%) 
DM+Hemiplegia Metoprolol+Amlodipine 1 (1%) 
Amlodipine 1 (1%) 
Amlodipine+Atenolol 1 (1%) 
Telmisartan+Hydrochlorothiazide 1 (1%) 
CVA+Hemiplegia Furosemide 1 (1%) 
Telmisartan+Hydrochlorothiazide 1 (1%) 
Losartan 2 (2%) 
Amlodipine+Atenolol 3 (3%) 
Metoprolol+Nifedipine 1 (1%) 
Amlodipine+Enalapril+Hydrochlorothiazide 1 (1%) 
Amlodipine 12 (12%) 
Prescribing patterns of antihypertensive were classified into two types like with co-morbidities 38%, and without co-morbidities 62%. Among these 
co-morbidities Cerebrovascular Accident+Hemiplegia 21%, Diabetic Mellitus 13%, Diabetic Mellitus + Hemiplegia 4% and the detailed drugs 
prescribed with co-morbid conditions were summarized in Table 4. Among these without co-morbidities were divided into two types of drugs 
prescribed with single drug 39% and combination drug therapy 23%, these results were summarized in Table 5. 
 
Table 5: Use of single and combined anti-hypertensive drugs in hypertension patients with co-morbidities 
Monotherapy  
Drugs 
Number and  
Percentage (%) 
Combination therapy drugs Number and  
Percentage (%) 
Calcium channel blockers  Metoprolol+ 
Amlodipine 
1 (1%) 
 Amlodipine 20 (20%) 
Angiotensin II receptor antagonists  Olmisartan+ 
Hydrochlorothiazide 
2 (2%) 
 Losartan 6 (6%) Losartan+ 
Hydrochlorothiazide 
2 (2%) 
 Telmisartan 6 (6%)   
β-blockers  Ramipril+ 
Hydrochlorothiazide 
1 (1%) 
 Atenolol 6 (6%) Atenolol+ 
Amlodipine 
3 (3%) 
Diuretics    





With increasing economic growth rate, India is not only facing the 
epidemic of Coronary Artery Disease but also of obesity, diabetes 
mellitus, and hypertension. Prevalence of hypertension has 
remained stable or has decreased in developed countries during the 
past decade; it has dramatically increased in developing countries 
like India.[6,7] Our finding shows that the prescribing patterns of anti- 
hypertensive drugs in geriatrics out-patient department during the 
study period was found to be higher in men 68% than in women 
32%. High blood pressure is more common in men than women. The 
women's were more likely to develop high blood pressure after 
menopause.[6] The risk of high blood pressure increases with age and 
in the early middle age.[4,6,8] In the present study 76% of the patients 
were Literate, 57% were employed, 31% of the patients having the 
monthly income of 5000-10000 and 20% were smokers and 15% 
were alcoholic patients. During the study period 80% of the patients 
were Pre-Hypertensive systolic (80-89 mmHg) and Diastolic (120-
139 mmHg) followed by Stage-I Hypertension and Stage-II 
Hypertension. The most commonly prescribed drug classes involved 
in the study was Calcium Channel Blockers 37% followed by 
Angiotensin II receptor antagonists 21% and the most commonly 
prescribed drugs in the study population were Amlodipine 37%, 
Losartan 11% and Telmisartan 10%. These results were compared 
with Datta S et al., and Almas A et al., conducted at tertiary care 
hospital shown that Calcium Channel Blocker- Amlodipine is the 
most commonly used antihypertensive monotherapy and Neal B et 
al., study results shown that the strong evidence of benefits of 
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calcium antagonists is provided by the overviews of placebo-
controlled trials.[9-12] The most common anti-hypertensive fixed dose 
combination therapy involved in the study was Telmisartan+ 
Hydrochlorothiazide 15% and most common two drug combination 
therapy involved in the study was Amlodipine+ Atenolol 7% 
followed by Metoprolol+Amlodipine 1% and these findings were not 
comparable with the studies conducted at tertiary care hospital in 
which beta blockers is used as the most common combination 
therapy.[9,10] Prescribing patterns of antihypertensive were classified 
into two types like with co-morbidities 38%, and without co-
morbidities 62%. Among these co-morbidities Cerebrovascular 
Accident (CVA)+Hemiplegia 21%, Diabetic Mellitus (DM) 13%, 
Diabetic Mellitus + Hemiplegia 4%. 
 
 




Our study shows that the most commonly prescribed drug classes 
involved were Calcium Channel Blockers followed by Angiotensin II 
receptor antagonists and the anti-hypertensive drug combinations 
among hypertensive patients were considerable and this practice 
positively impacted on the overall blood pressure control. In order 
to promote the rational prescribing drugs and hospital formularies 
in special committees are useful in reducing the misuse of drugs 
especially in poly-pharmacy and in the treatment of hypertension.  
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